AWS Partner
AWS Partner

Why Saama + AWS?

Saama and Amazon Web Services (AWS), together, can help life science companies solve critical challenges, such as high volume of data and bringing therapies to market faster, with the most advanced artificial intelligence (AI) and analytics solutions within clinical development– all embedded within a scalable, SaaS-based platform backed by AWS.

Saama brings strong clinical development domain expertise, with 20+ years of experience and experts with decades of experience in key clinical functional areas such as data management, clinical operations, information technology, and more.

Saama’s platform eliminates manual, resource-intensive activities, allowing life science organizations to optimize productivity as well as gain deeper insights into patients’ behaviors and their real-time response to treatments.

And it’s not just talk. When using Saama’s platform, life science organizations have been able to:

  • Reduce query identification and generation times by as much as 90% per query
  • Realize up to 50% time savings for study data transformations,
  • Reduce time from data entry to analysis by more than 35%, and more.

Saama’s AI/ML Models Are Ready Today

It takes time to accurately train new AI/ML models. Saama has put in the work so you don’t have to.

“(SDQ) saved us an entire month. It really has had a significant impact on the first-pass quality of our clinical data and the speed through which we can move things along and make decisions.”

Head of Data Monitoring, Top 3 Global Pharmaceutical Company

"Our industry has coalesced around AWS as the strategic choice for cloud related services. Saama has built our differentiated AI-driven platform as a cloud-native offering that relies significantly on the scalability and reliability that AWS provides. The partnership between AWS and Saama brings significant value and optionality to our customers in the way we can support them and ensure that they have access to the right forward looking solutions for their strategic imperatives."
Lisa Moneymaker
Lisa Moneymaker
Chief Technology and Product Officer, Saama
"The partnership between AWS and Saama exemplifies a "better together" strategy by pairing the top data platform with the leading AI analytics platform in Life Sciences to provide a seamless experience for our pharma, biotech, and CRO clients while better managing their clinical trial data. We at Saama are thrilled to be partnered with AWS."
Matt Johnson
Matt Johnson
VP Partnerships, Saama


Check out Saama’s resources to learn more about how we accelerate clinical trials- intelligently.

Case Studies

Explore our customer success stories to see how Saama can accelerate your clinical trial.


Check out Saama’s blog, including our AI blog series.

Fact Sheets

Browse our fact sheets to learn more about Saama’s platform.

Smart Data Quality Infographic

 See how Saama reduces query times from 30 minutes to 3 minutes.

Platform Overview

Check out overview videos of the Saama platform. 

In The News

Saama Launches Industry’s First AI-driven Data Platform to Accelerate Clinical Development

Suite of AI-enhanced Saas solutions automates routine processes and provides a holistic view of trial operations and patient behaviors in real time.

See What Saama Has Been Up To

See for yourself what Saama has been up to, and the impact they have had on the clinical trial industry.

Women In Science

Interview With Lisa Moneymaker, CTO/CPO, Saama, in OutsourcingPharma, where she discusses her ‘atypical’ career in Pharma.

FDA’s Draft Guidance- Hit or Miss?

Saama’s Norma Rodriguez, Vice President, Global Head of Quality Assurance & Compliance, recently sat down with Clinical Trials Arena to discuss the FDA’s draft guidance for decentralized clinical trials.

Investment Reports Interview With Vivek Sharma, CEO, Saama

Vivek Sharma, CEO, Saama, discusses the challenges facing today’s clinical trials environment, Saama’s role in accelerating COVID-19 vaccine trials, and the company’s plans for the future.